Miriam Djelani

Senior Medical Affairs leader with 20 years of experience across diverse therapeutic areas. Provide disciplinary and strategic leadership for Medical Teams. Proven expertise in cross-functional leadership, strategic portfolio management, and aligning medical strategies with business goals. Skilled in matrix environments, transforming scientific insights into impactful solutions. My transformational leadership fosters empowerment, accountability and inclusion, driving high-impact healthcare innovation.

Led the PH Medical Team with full strategic and operational responsibility, integrating local market insights into global strategies and collaborating with international stakeholders. Worked closely with Commercial, HEMAR and Regulatory teams to shape the strategic direction and optimize product impact. Strengthened scientific engagement with key customers. Aligned local market insights with global strategies. Introduced agile methodologies, boosting team productivity and market responsiveness.

Strategic and operational responsibility for 25+ late lifecycle products across Neuroscience, Oncology, Hematology, and Internal Medicine. Led the Medical Team and MAST VOT, collaborating with CVT and international teams. Drove cross-functional initiatives to develop and execute long-term medical strategies aligned with business goals. Led five product divestments and four portfolio transitions with new indications, ensuring seamless market adaptation. Developed a digital database of products since 1945.

Medical expert for managing 25+ post-exclusivity products across Hematology, Oncology, and Internal Medicine. Contributed to CVT initiatives, focusing on optimizing product lifecycle strategies and supporting business objectives. Developed the German VOT strategy leading to adoption for ESO-level rollout. Inclusion of nine VOT products on the WHO Essential Medicines List, ensuring global access. Supported treatment of 800,000+ patients by ensuring continued access to vital VOT therapies.

Medical expert for ADHD, Alzheimer’s disease, chronic kidney disease, asthma, and epilepsy. Engaged with scientific communities and developed Medical Affairs Product Plans. Led the design and execution of local study concepts as Study Responsible Physician or Country Representative for international projects, driving scientific and market success.

Medical Expert in dermatology and migraine, responsible for developing scientific content and delivering medical training to MSLs, sales teams, and other employees. SRP for Germany-based studies, managing study reports and publications.

Conducted in-depth research and delivered scientifically sound responses to medical inquiries across various therapeutic areas. Ensured clear and effective communication with internal and external stakeholders.

- Part-Time Executive MBA | Mannheim Business School | Class of 2026 - Triple Crown Accredited (AACSB, EQUIS, AMBA) - Focus: Strategic Leadership, Business Innovation & Digital Transformation